rs4986954

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_000198.4(HSD3B2):​c.220G>A​(p.Asp74Asn) variant causes a missense change. The variant allele was found at a frequency of 0.000617 in 1,613,814 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. D74D) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0035 ( 7 hom., cov: 32)
Exomes 𝑓: 0.00031 ( 1 hom. )

Consequence

HSD3B2
NM_000198.4 missense

Scores

1
6
11

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 6.64

Publications

4 publications found
Variant links:
Genes affected
HSD3B2 (HGNC:5218): (hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2) The protein encoded by this gene is a bifunctional enzyme that catalyzes the oxidative conversion of delta(5)-ene-3-beta-hydroxy steroid, and the oxidative conversion of ketosteroids. It plays a crucial role in the biosynthesis of all classes of hormonal steroids. This gene is predominantly expressed in the adrenals and the gonads. Mutations in this gene are associated with 3-beta-hydroxysteroid dehydrogenase, type II, deficiency. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Oct 2009]
HSD3B2 Gene-Disease associations (from GenCC):
  • congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010008693).
BP6
Variant 1-119419495-G-A is Benign according to our data. Variant chr1-119419495-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 720898.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 7 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HSD3B2NM_000198.4 linkc.220G>A p.Asp74Asn missense_variant Exon 3 of 4 ENST00000369416.4 NP_000189.1 P26439-1A0A024R0F9
HSD3B2NM_001166120.2 linkc.220G>A p.Asp74Asn missense_variant Exon 3 of 4 NP_001159592.1 P26439-1A0A024R0F9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HSD3B2ENST00000369416.4 linkc.220G>A p.Asp74Asn missense_variant Exon 3 of 4 1 NM_000198.4 ENSP00000358424.3 P26439-1

Frequencies

GnomAD3 genomes
AF:
0.00352
AC:
536
AN:
152170
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0125
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000916
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000793
AC:
199
AN:
250902
AF XY:
0.000568
show subpopulations
Gnomad AFR exome
AF:
0.0110
Gnomad AMR exome
AF:
0.000492
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000177
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000314
AC:
459
AN:
1461526
Hom.:
1
Cov.:
31
AF XY:
0.000268
AC XY:
195
AN XY:
727084
show subpopulations
African (AFR)
AF:
0.0112
AC:
376
AN:
33464
American (AMR)
AF:
0.000514
AC:
23
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39670
South Asian (SAS)
AF:
0.0000464
AC:
4
AN:
86250
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.000521
AC:
3
AN:
5760
European-Non Finnish (NFE)
AF:
0.00000450
AC:
5
AN:
1111754
Other (OTH)
AF:
0.000795
AC:
48
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
31
61
92
122
153
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00352
AC:
536
AN:
152288
Hom.:
7
Cov.:
32
AF XY:
0.00344
AC XY:
256
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.0125
AC:
519
AN:
41550
American (AMR)
AF:
0.000915
AC:
14
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68032
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
28
56
83
111
139
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00169
Hom.:
0
Bravo
AF:
0.00359
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00885
AC:
39
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00106
AC:
129
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Mar 29, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 22, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

3 beta-Hydroxysteroid dehydrogenase deficiency Benign:2
Apr 28, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -

Jun 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.094
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.34
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.26
T;T;T
Eigen
Benign
-0.0023
Eigen_PC
Benign
0.018
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.92
D;D;.
MetaRNN
Benign
0.010
T;T;T
MetaSVM
Uncertain
-0.26
T
MutationAssessor
Benign
1.0
L;.;L
PhyloP100
6.6
PrimateAI
Benign
0.43
T
PROVEAN
Benign
0.52
N;N;N
REVEL
Uncertain
0.38
Sift
Uncertain
0.010
D;D;D
Sift4G
Uncertain
0.043
D;D;D
Polyphen
0.46
P;.;P
Vest4
0.22
MVP
0.91
MPC
0.36
ClinPred
0.083
T
GERP RS
3.9
Varity_R
0.22
gMVP
0.11
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4986954; hg19: chr1-119962118; API